Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer

Abstract

Analysis of the molecular susceptibilities triggered by ATM deficiency in PDAC allow elaboration of an efficient mutation-specific combinational therapeutic approach that can be also implemented in a genotype-independent manner by ATM inhibition.